Redox Regulation of Lung Endothelial PERK, Unfolded Protein Response (UPR) and Proliferation via NOX1: Targeted Inhibition as a Potential Therapy for PAH
RNA-seq (gene expression) · human · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 12 samples: 3 × HPAEC_NORMOXIA_siCT vs 3 × HPAEC_NORMOXIA_siNOX1 vs 3 × HPAEC_HYPOXIA_siCT vs 3 × HPAEC_HYPOXIA_siNOX1Groups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Redox regulation of lung endothelial PERK, unfolded protein response (UPR) and proliferation via NOX1: Targeted inhibition as a potential therapy for PAHRedox biology · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE291410_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1233320 and SRA study SRP568739. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 4 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8834879 HPAEC_NORMOXIA_siCTR-1 HPAEC_NORMOXIA_siCT
- GSM8834880 HPAEC_NORMOXIA_siCTR-2 HPAEC_NORMOXIA_siCT
- GSM8834881 HPAEC_NORMOXIA_siCTR-3 HPAEC_NORMOXIA_siCT
- GSM8834882 HPAEC_NORMOXIA_siNOX1-1 HPAEC_NORMOXIA_siNOX1
- GSM8834883 HPAEC_NORMOXIA_siNOX1-2 HPAEC_NORMOXIA_siNOX1
- GSM8834884 HPAEC_NORMOXIA_siNOX1-3 HPAEC_NORMOXIA_siNOX1
- GSM8834885 HPAEC_HYPOXIA_siCTR-1 HPAEC_HYPOXIA_siCT
- GSM8834886 HPAEC_HYPOXIA_siCTR-2 HPAEC_HYPOXIA_siCT
- GSM8834887 HPAEC_HYPOXIA_siCTR-3 HPAEC_HYPOXIA_siCT
- GSM8834888 HPAEC_HYPOXIA_siNOX1-1 HPAEC_HYPOXIA_siNOX1
- GSM8834889 HPAEC_HYPOXIA_siNOX1-2 HPAEC_HYPOXIA_siNOX1
- GSM8834890 HPAEC_HYPOXIA_siNOX1-3 HPAEC_HYPOXIA_siNOX1
- GSE281408 TNF-α inhibits the chemotherapy resistance caused by upregulation of the PERK-ATF4 pathway in colorectal cancer cells 16 samples shares perk, upr
- GSE298762 NSAIDS-XDR-TB clinical trial: A randomized pilot study to estimate the potential efficacy and safety of using adjunctive ibuprofen for the treatment of pre-XDR and XDR tuberculosis 73 samples shares upr, potential
- GSE274024 NOX4/NOX1 dual inhibition in cholangiocarcinoma as an effective approach to target TGF-beta protumorigenic actions in cancer associated fibroblasts 45 samples shares nox1, inhibition
- GSE312843 RBM39 Modulates UPR Signaling Through Alternative Splicing of IRE1α/ERN1 [Spliceosome_Inhibition_RNA-Seq] 20 samples shares upr, inhibition
- GSE303125 Inhibition of heme biosynthesis triggers cuproptosis in acute myeloid leukemia [RNA-Seq OCIAML3_ALAS1_KO_and_SA] 12 samples shares upr, inhibition
- GSE279105 LKB1 Loss Sensitizes Lung Cancer Cells to PRMT5 inhibition by upregulating NNMT 12 samples shares upr, inhibition
- GSE308716 Knockdown of TRIM35 supresses cell proliferation, metastasis, and glycolysis in papillary thyroid cancer cells 12 samples shares upr, proliferation
- GSE190773 KMT2A-driven cyclin D2 upregulation and chronic inflammation as potential drivers of sporadic parathyroid adenoma pathogenesis 8 samples shares upr, potential
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.